Based on the results of the present study, a novel inhibitor of DDR1, 7rh benzamide, is potentially efficacious in preventing tumor recurrence after curative resection in DDR1-expressing gastric cancer through the suppression of cancer cell migration and tumorigenic abilities. This evidence concerns the gene DDR1 and neoplasm.